Clinical Trial Update: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic, open-label randomized trial compares treat-and-extend versus fixed-dosing regimens of faricimab for diabetic macular edema; the study is mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• VABYSMO (faricimab)

Snippet

Sponsor: McMaster University | Conditions: Diabetic Macular Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING